Modulation of calcium signaling of angiotensin AT1, endothelin ETA, and ETBreceptors by silibinin, quercetin, crocin, diallyl sulfides, and ginsenoside Rb1

Planta Medica

Volumn 81, Issue 8, 2015, Pages 670-678

  Bahem, Ruba ^a   Hoffmann, Anja ^a   Azonpi, Arnaud ^a   Caballero George, Catherina ^b   Vanderheyden, Patrick ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b Institute for Scientific Research and High Technology Services   (Panama)

Author keywords

angiotensin II; calcium signaling; endothelin 1; G protein coupled receptors; silibinin

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; CALCIUM ION; CANDESARTAN; CROCIN; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); DIALLYL DISULFIDE; DIALLYL TRISULFIDE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; GINSENOSIDE RB 1; LOSARTAN; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; QUERCETIN; SILIBININ; ALLYL COMPOUND; ALLYL SULFIDE; ANGIOTENSIN DERIVATIVE; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; CAROTENOID; ENDOTHELIN; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; GINSENOSIDE; SILYMARIN; SULFIDE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CHO CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; EC50; NONHUMAN; PROTEIN EXPRESSION; SILYBUM MARIANUM; ANIMAL; CRICETULUS; DRUG EFFECTS; FEMALE; HAMSTER; HUMAN;

CRICETULUS GRISEUS; SILYBUM MARIANUM;

ALLYL COMPOUNDS; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSINS; ANIMALS; CALCIUM SIGNALING; CAROTENOIDS; CHO CELLS; CRICETINAE; CRICETULUS; ENDOTHELIN RECEPTOR ANTAGONISTS; ENDOTHELIN-1; ENDOTHELINS; FEMALE; GINSENOSIDES; HUMANS; QUERCETIN; RECEPTORS, ANGIOTENSIN; RECEPTORS, ENDOTHELIN; SILYMARIN; SULFIDES;

EID: 84946240988     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0034-1383408     Document Type: Article

References (41)

1. de Gasparo M., Catt K. J., Inagami T., Wright J. W., Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev: 2000; 52 415 472
2. Atlas S. A. The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition. J Manag Care Pharm: 2007; 13 9 20
3. Weir M. R., Dzau V. J. The renin-angiotensin-aldosterone system: a specific target for hypertension management. Am J Hypertens: 1999; 12 205S 213S
4. Miyauchi T., Masaki T. Pathophysiology of endothelin in the cardiovascular system. Annu Rev Physiol: 1999; 61 391 415
5. Nakas-Icindic E., Zaciragic A., Hadzovic A., Avdagic N. Endothelin in health and disease. Bosn J Basic Med Sci: 2004; 4 31 34
6. Davenport A. P. International Union of Pharmacology. XXIX. Update on endothelin receptor nomenclature. Pharmacol Rev: 2002; 54 219 226
7. Davenport A. P., Battistini B. Classification of endothelin receptors and antagonists in clinical development. Clin Sci (Lond): 2002; 103 48 1S 3S
8. Maione F., Cicala C., Musciacco G., De Feo V., Amat A. G., Ialenti A., Mascolo N. Phenols, alkaloids and terpenes from medicinal plants with antihypertensive and vasorelaxant activities. A review of natural products as leads to potential therapeutic agents. Nat Prod Commun: 2013; 8 539 544
9. Stoclet J. C., Chataigneau T., Ndiaye M., Oak M. H., El Bedoui J., Chataigneau M., Schini-Kerth V. B. Vascular protection by dietary polyphenols. Eur J Pharmacol: 2004; 500 299 313
10. Ulrich-Merzenich G., Panek D., Zeitler H., Vetter H., Wagner H. Drug development from natural products: exploiting synergistic effects. Indian J Exp Biol: 2010; 48 208 219
11. Gazak R., Walterova D., Kren V. Silybin and silymarin-new and emerging applications in medicine. Curr Med Chem: 2007; 14 315 338
12. Li Volti G., Salomone S., Sorrenti V., Mangiameli A., Urso V., Siarkos I., Galvano F., Salamone F. Effect of silibinin on endothelial dysfunction and ADMA levels in obese diabetic mice. Cardiovasc Diabetol: 2011; 10 62
13. Ai W., Zhang Y., Tang Q. Z., Yan L., Bian Z. Y., Liu C., Huang H., Bai X., Yin L., Li H. Silibinin attenuates cardiac hypertrophy and fibrosis through blocking EGFR-dependent signaling. J Cell Biochem: 2010; 110 1111 1122
14. Khurana S., Venkataraman K., Hollingsworth A., Piche M., Tai T. C. Polyphenols: benefits to the cardiovascular system in health and in aging. Nutrients: 2013; 5 3779 3827
15. Imenshahidi M., Razavi B. M., Faal A., Gholampoor A., Mousavi S. M., Hosseinzadeh H. Effects of chronic crocin treatment on desoxycorticosterone acetate (doca)-salt hypertensive rats. Iran J Basic Med Sci: 2014; 17 9 13
16. Imenshahidi M., Razavi B. M., Faal A., Gholampoor A., Mousavi S. M., Hosseinzadeh H. The Effect of Chronic Administration of Saffron (Crocus sativus) Stigma Aqueous Extract on Systolic Blood Pressure in Rats. Jundishapur J Nat Pharm Prod: 2013; 8 175 179
17. Taira S., Ikeda R., Yokota N., Osaka I., Sakamoto M., Kato M., Sahashi Y. Mass spectrometric imaging of ginsenosides localization in Panax ginseng root. Am J Chin Med: 2010; 38 485 493
18. Wang C. Z., Kim K. E., Du G. J., Qi L. W., Wen X. D., Li P., Bauer B. A., Bissonnette M. B., Musch M. W., Chang E. B., Yuan C. S. Ultra-performance liquid chromatography and time-of-flight mass spectrometry analysis of ginsenoside metabolites in human plasma. Am J Chin Med: 2011; 39 1161 1171
19. Li J., Shao Z. H., Xie J. T., Wang C. Z., Ramachandran S., Yin J. J., Aung H., Li C. Q., Qin G., Vanden Hoek T., Yuan C. S. The effects of ginsenoside Rb1 on JNK in oxidative injury in cardiomyocytes. Arch Pharm Res: 2012; 35 1259 1267
20. Yun H. M., Ban J. O., Park K. R., Lee C. K., Jeong H. S., Han S. B., Hong J. T. Potential therapeutic effects of functionally active compounds isolated from garlic. Pharmacol Ther: 2014; 142 183 195
21. Benavides G. A., Squadrito G. L., Mills R. W., Patel H. D., Isbell T. S., Patel R. P., Darley-Usmar V. M., Doeller J. E., Kraus D. W. Hydrogen sulfide mediates the vasoactivity of garlic. Proc Natl Acad Sci U S A: 2007; 104 17977 17982
22. Nikolaou A., Van den Eynde I., Tourwe D., Vauquelin G., Toth G., Mallareddy J. R., Poglitsch M., Van Ginderachter J. A., Vanderheyden P. M. [3H]IVDE77, a novel radioligand with high affinity and selectivity for the insulin-regulated aminopeptidase. Eur J Pharmacol: 2013; 702 93 102
23. Verheijen I., Vanderheyden P. M., De Backer J. P., Vauquelin G. AT1 receptor antagonists. Curr Med Chem Cardiovasc Hematol Agents: 2004; 2 69 77
24. Vanderheyden P. M., Fierens F. L., Vauquelin G. Angiotensin II type 1 receptor antagonists. Why do some of them produce insurmountable inhibition? Biochem Pharmacol: 2000; 60 1557 1563
25. Arunlakshana O., Schild H. O. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother: 1959; 14 48 58
26. Caballero-George C., Vanderheyden P. M., De Bruyne T., Shahat A. A., Van den Heuvel H., Solis P. N., Gupta M. P., Claeys M., Pieters L., Vauquelin G., Vlietinck A. J. In vitro inhibition of [3H]-angiotensin II binding on the human AT1 receptor by proanthocyanidins from Guazuma ulmifolia bark. Planta Med: 2002; 68 1066 1071
27. Singh R. P., Tyagi A. K., Zhao J., Agarwal R. Silymarin inhibits growth and causes regression of established skin tumors in SENCAR mice via modulation of mitogen-activated protein kinases and induction of apoptosis. Carcinogenesis: 2002; 23 499 510
28. Zhou B., Wu L. J., Li L. H., Tashiro S., Onodera S., Uchiumi F., Ikejima T. Silibinin protects against isoproterenol-induced rat cardiac myocyte injury through mitochondrial pathway after up-regulation of SIRT1. J Pharmacol Sci: 2006; 102 387 395
29. Dayoub O., Andriantsitohaina R., Clere N. Pleiotropic beneficial effects of epigallocatechin gallate, quercetin and delphinidin on cardiovascular diseases associated with endothelial dysfunction. Cardiovasc Hematol Agents Med Chem: 2013; 11 249 264
30. Duarte J., Perez Vizcaino F., Utrilla P., Jimenez J., Tamargo J., Zarzuelo A. Vasodilatory effects of flavonoids in rat aortic smooth muscle. Structure-activity relationships. Gen Pharmacol: 1993; 24 857 862
31. Perez-Vizcaino F., Ibarra M., Cogolludo A. L., Duarte J., Zaragoza-Arnaez F., Moreno L., Lopez-Lopez G., Tamargo J. Endothelium-independent vasodilator effects of the flavonoid quercetin and its methylated metabolites in rat conductance and resistance arteries. J Pharmacol Exp Ther: 2002; 302 66 72
32. Perez A., Gonzalez-Manzano S., Jimenez R., Perez-Abud R., Haro J. M., Osuna A., Santos-Buelga C., Duarte J., Perez-Vizcaino F. The flavonoid quercetin induces acute vasodilator effects in healthy volunteers: correlation with beta-glucuronidase activity. Pharmacol Res: 2014; 89 11 18
33. Perez-Vizcaino F., Duarte J. Flavonols and cardiovascular disease. Mol Aspects Med: 2010; 31 478 494
34. Khoo N. K., White C. R., Pozzo-Miller L., Zhou F., Constance C., Inoue T., Patel R. P., Parks D. A. Dietary flavonoid quercetin stimulates vasorelaxation in aortic vessels. Free Radic Biol Med: 2010; 49 339 347
35. Nifli A. P., Theodoropoulos P. A., Munier S., Castagnino C., Roussakis E., Katerinopoulos H. E., Vercauteren J., Castanas E. Quercetin exhibits a specific fluorescence in cellular milieu: a valuable tool for the study of its intracellular distribution. J Agric Food Chem: 2007; 55 2873 2878
36. Boskabady M. H., Aslani M. R. Relaxant effect of Crocus sativus (saffron) on guinea-pig tracheal chains and its possible mechanisms. J Pharm Pharmacol: 2006; 58 1385 1390
37. He S. Y., Qian Z. Y., Tang F. T. Effect of crocin on intracellular calcium concentration in cultured bovine aortic smooth muscle cells. Yao Xue Xue Bao: 2004; 39 778 781
38. Demaegdt H., Vanderheyden P., De Backer J. P., Mosselmans S., Laeremans H., Le M. T., Kersemans V., Michotte Y., Vauquelin G. Endogenous cystinyl aminopeptidase in Chinese hamster ovary cells: characterization by [125I]Ang IV binding and catalytic activity. Biochem Pharmacol: 2004; 68 885 892
39. Le Poul E., Hisada S., Mizuguchi Y., Dupriez V. J., Burgeon E., Detheux M. Adaptation of aequorin functional assay to high throughput screening. J Biomol Screen: 2002; 7 57 65
40. Iredale P. A., Hill S. J. Increases in intracellular calcium via activation of an endogenous P2-purinoceptor in cultured CHO-K1 cells. Br J Pharmacol: 1993; 110 1305 1310
41. Lecoeur H., Ledru E., Prevost M. C., Gougeon M. L. Strategies for phenotyping apoptotic peripheral human lymphocytes comparing ISNT, annexin-V and 7-AAD cytofluorometric staining methods. J Immunol Methods: 1997; 209 111 123